If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Hypogonadism

New Formulations of Androderm Approved

Stephan Cho October 21, 2011

The FDA has approved two lower-dose formulations for Androderm, a once-daily transdermal patch for men with low testosterone.

Testosterone Therapy May Not Improve Erectile Dysfunction

John Schieszer October 18, 2011

ORLANDO, Fla.—Testosterone supplementation in elderly men with borderline low testosterone levels may not improve erectile dysfunction (ED) compared with placebo, new findings suggest.

Male Hypogonadism Linked to Ratio of Finger Lengths

Jody A. Charnow July 07, 2011

The ratio of the second and fourth finger lengths (2D/4D ratio) may predict which men have testosterone deficiency, researchers reported.

Underarm Testosterone Therapy Cleared

John Schieszer June 28, 2011

WASHINGTON, D.C.—The FDA has approved the first and only testosterone therapy applied to the underarm.

FDA Approves New AndroGel Formulation

Delicia Honen Yard June 16, 2011

The FDA has approved Abbott's AndroGel 1.62%, a testosterone gel that restores levels of the hormone in hypogonadal men with half the volume of gel at the starting dose than delivered in AndroGel 1%.

Hypogonadism and Metabolic Syndrome

Jody A. Charnow June 09, 2011

Low testosterone increases fat mass and visceral obesity, which is associated with insulin resistance.

Relationships of Testosterone and Prostate Cancer: A 2011 Perspective

By Kelly Chiles, MD and Stanton Honig, MD May 01, 2011

A history of prostate cancer has generally been a contraindication for testosterone therapy, but the clinical model may be changing.

Testosterone Safe for Prostates

Jody A. Charnow March 20, 2011

VIENNA—Testosterone replacement therapy benefits hypogonadal men without adversely affecting prostate safety, according to the largest international trial of hypogonadal men receiving the treatment.

Saliva Test Identifies Hypogonadism in ESRD Patients

Tasheema Prince February 07, 2011

Salivary testosterone (Sal-T) can be used to diagnose androgen deficiency reliably in men with end-stage renal disease (ESRD), according to a Brazilian study.

DHT Does Not Affect Prostate Growth

Delicia Honen Yard January 24, 2011

Dihydrotestosterone (DHT) treatment over two years does not halt prostate growth, according to study findings published in the Annals of Internal Medicine (2010;153:621-632).

Low Testosterone May Raise Death Risk in Men with CHD

Jody A. Charnow January 05, 2011

A study of 930 men with coronary heart disease (CHD) showed that those who had testosterone deficiency were at increased risk of death.

FDA Clears Testosterone Gel

Jody A. Charnow January 04, 2011

The FDA has approved a testosterone replacement therapy gel, a colorless and odorless preparation applied with one finger to the front and inner thighs.

Standardization: The Future of Testosterone Testing

Delicia Honen Yard December 15, 2010

Endocrinologist William Rosner, MD, Professor of Medicine at Columbia University in New York, explains to Renal & Urology News what impending testosterone-testing standardization—and the current lack of it—means to urology practice and research.

Hypogonadism Linked to Statin Use

Jody A. Charnow February 17, 2010

Statin therapy may induce primary hypogonadism and should be considered a possible confounding factor when evaluating testosterone levels in patients with erectile dysfunction (ED), according to Italian researchers.

Testosterone Treatment May Have Non-Sexual Benefits

John Schieszer September 18, 2009

In elderly hypogonadal men, it can improve components of the metabolic syndrome, a study found

Low Testosterone Increases Mortality Risk

John Schieszer September 01, 2008

SAN FRANCISCO—Low serum testosterone levels may be associated with an increased risk of death from cardiovascular causes and cancer, independent of age and other risk factors, according to a recent population-based study.

Low Testosterone May Increase Mortality

John Schieszer August 01, 2007

TORONTO—Androgen deficiency in men aged 50 years and older may be associated with an increased risk of death, independent of adiposity and lifestyle choices, a study suggests. This association may be explained, in part, by the metabolic syndrome and elevated markers of inflammation.